YoVDO

CD3ζ as a Novel Integration Site for Reprogramming Immune Cells with Chimeric Antigen Receptors

Offered By: Labroots via YouTube

Tags

Immunotherapy Courses Oncology Courses Infectious Diseases Courses Autoimmune Diseases Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore a groundbreaking webinar on CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors, presented by Dr. Dimitrios L. Wagner, head of Research and Development Unit at Berlin Center for Advanced Therapies. Delve into the exciting therapeutic potential of CAR-reprogrammed immune cells for oncology, autoimmune diseases, transplant medicine, and infections. Examine the challenges of current CAR-T therapies, including CAR-signaling regulation and limited accessibility due to expensive personalized manufacturing. Gain insights into innovative approaches to overcome these limitations and advance the field of immunotherapy. Earn PACE credits by watching the webinar and following the provided instructions. Connect with Labroots on various social media platforms for more scientific content and updates.

Syllabus

CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors


Taught by

Labroots

Related Courses

Fundamentals of Immunology: Death by Friendly Fire
Rice University via edX
Fundamentals of Immunology: Inflammation, Tolerance, Autoimmunity
Rice University via Coursera
Introduction à l'immunologie: méthodes et applications médicales
École Polytechnique Fédérale de Lausanne via edX
Fundamentals of Immunology
Rice University via Coursera
Immunology with Hematology
University of California, Irvine via YouTube